523 related articles for article (PubMed ID: 19038308)
101. Local biosynthesis of estrogen in human endometrial carcinoma through tumor-stromal cell interactions.
Takahashi-Shiga N; Utsunomiya H; Miki Y; Nagase S; Kobayashi R; Matsumoto M; Niikura H; Ito K; Yaegashi N
Clin Cancer Res; 2009 Oct; 15(19):6028-34. PubMed ID: 19789322
[TBL] [Abstract][Full Text] [Related]
102. Discovery of nonsteroidal 17beta-hydroxysteroid dehydrogenase 1 inhibitors by pharmacophore-based screening of virtual compound libraries.
Schuster D; Nashev LG; Kirchmair J; Laggner C; Wolber G; Langer T; Odermatt A
J Med Chem; 2008 Jul; 51(14):4188-99. PubMed ID: 18533708
[TBL] [Abstract][Full Text] [Related]
103. The dual sex hormone specificity for human reductive 17β-hydroxysteroid dehydrogenase type 7: Synergistic function in estrogen and androgen control.
Thériault JF; Lin SX
J Steroid Biochem Mol Biol; 2019 Feb; 186():61-65. PubMed ID: 30227243
[TBL] [Abstract][Full Text] [Related]
104. Cinnamates and cinnamamides inhibit fungal 17beta-hydroxysteroid dehydrogenase.
Kristan K; Starcević S; Brunskole M; Rizner TL; Gobec S
Mol Cell Endocrinol; 2006 Mar; 248(1-2):239-41. PubMed ID: 16337334
[TBL] [Abstract][Full Text] [Related]
105. In vivo and in vitro expression of steroid-converting enzymes in human breast tumours: associations with interleukin-6.
Speirs V; Walton DS; Hall MC; Atkin SL
Br J Cancer; 1999 Oct; 81(4):690-5. PubMed ID: 10574257
[TBL] [Abstract][Full Text] [Related]
106. Androsterone 3alpha-ether-3beta-substituted and androsterone 3beta-substituted derivatives as inhibitors of type 3 17beta-hydroxysteroid dehydrogenase: chemical synthesis and structure-activity relationship.
Tchédam Ngatcha B; Luu-The V; Labrie F; Poirier D
J Med Chem; 2005 Aug; 48(16):5257-68. PubMed ID: 16078844
[TBL] [Abstract][Full Text] [Related]
107. Sex steroid-producing enzymes in human breast cancer.
Suzuki T; Miki Y; Nakamura Y; Moriya T; Ito K; Ohuchi N; Sasano H
Endocr Relat Cancer; 2005 Dec; 12(4):701-20. PubMed ID: 16322318
[TBL] [Abstract][Full Text] [Related]
108. Estradiol-adenosine hybrid compounds designed to inhibit type 1 17beta-hydroxysteroid dehydrogenase.
Poirier D; Boivin RP; Tremblay MR; Bérubé M; Qiu W; Lin SX
J Med Chem; 2005 Dec; 48(26):8134-47. PubMed ID: 16366595
[TBL] [Abstract][Full Text] [Related]
109. Expression analysis of the genes involved in estradiol and progesterone action in human ovarian endometriosis.
Smuc T; Pucelj MR; Sinkovec J; Husen B; Thole H; Lanisnik Rizner T
Gynecol Endocrinol; 2007 Feb; 23(2):105-11. PubMed ID: 17454161
[TBL] [Abstract][Full Text] [Related]
110. Influence of estrogens on the androgen metabolism in different subunits of human hair follicles.
Niiyama S; Happle R; Hoffmann R
Eur J Dermatol; 2001; 11(3):195-8. PubMed ID: 11358723
[TBL] [Abstract][Full Text] [Related]
111. Novel estrone mimetics with high 17beta-HSD1 inhibitory activity.
Oster A; Klein T; Werth R; Kruchten P; Bey E; Negri M; Marchais-Oberwinkler S; Frotscher M; Hartmann RW
Bioorg Med Chem; 2010 May; 18(10):3494-505. PubMed ID: 20413314
[TBL] [Abstract][Full Text] [Related]
112. Active site analysis of 17beta-hydroxysteroid dehydrogenase type 1 enzyme complexes with SPROUT.
Alho-Richmond S; Lilienkampf A; Wähälä K
Mol Cell Endocrinol; 2006 Mar; 248(1-2):208-13. PubMed ID: 16412556
[TBL] [Abstract][Full Text] [Related]
113. Oestrogen producing enzymes and mammary carcinogenesis: a review.
Subramanian A; Salhab M; Mokbel K
Breast Cancer Res Treat; 2008 Sep; 111(2):191-202. PubMed ID: 17934808
[TBL] [Abstract][Full Text] [Related]
114. Synthesis of 16β-derivatives of 3-(2-bromoethyl)-estra-1,3,5(10)-trien-17β-ol as inhibitors of 17β-HSD1 and/or steroid sulfatase for the treatment of estrogen-dependent diseases.
Lespérance M; Roy J; Djiemeny Ngueta A; Maltais R; Poirier D
Steroids; 2021 Aug; 172():108856. PubMed ID: 33945801
[TBL] [Abstract][Full Text] [Related]
115. New drug-like hydroxyphenylnaphthol steroidomimetics as potent and selective 17β-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of estrogen-dependent diseases.
Marchais-Oberwinkler S; Wetzel M; Ziegler E; Kruchten P; Werth R; Henn C; Hartmann RW; Frotscher M
J Med Chem; 2011 Jan; 54(2):534-47. PubMed ID: 21189020
[TBL] [Abstract][Full Text] [Related]
116. Phytoestrogens inhibit human 17beta-hydroxysteroid dehydrogenase type 5.
Krazeisen A; Breitling R; Möller G; Adamski J
Mol Cell Endocrinol; 2001 Jan; 171(1-2):151-62. PubMed ID: 11165023
[TBL] [Abstract][Full Text] [Related]
117. Loss of estrogen inactivation in colonic cancer.
English MA; Kane KF; Cruickshank N; Langman MJ; Stewart PM; Hewison M
J Clin Endocrinol Metab; 1999 Jun; 84(6):2080-5. PubMed ID: 10372714
[TBL] [Abstract][Full Text] [Related]
118. Integrated view on 17beta-hydroxysteroid dehydrogenases.
Moeller G; Adamski J
Mol Cell Endocrinol; 2009 Mar; 301(1-2):7-19. PubMed ID: 19027824
[TBL] [Abstract][Full Text] [Related]
119. Oestrogen-synthesising enzymes and breast cancer.
Kulendran M; Salhab M; Mokbel K
Anticancer Res; 2009 Apr; 29(4):1095-109. PubMed ID: 19414351
[TBL] [Abstract][Full Text] [Related]
120. Estradiol inhibits the estrone sulfatase activity in normal and cancerous human breast tissues.
Chetrite GS; Cortes-Prieto JC; Philippe JC; Pasqualini JR
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):289-92. PubMed ID: 17481887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]